Related Experiment Video
Updated: Aug 3, 2026
09:18
Electrophysiological Measurements and Analysis of Nociception in Human Infants
Published on: December 20, 2011
Recent pharmacological advances in paediatric analgesics
1University of Auckland, Auckland, New Zealand, and Department of Anaesthesia and Pain Management, Royal Children's Hospital, Victoria, Australia. briana@adhb.govt.nz
Summary
Understanding how children process pain medication is crucial. This review explores pharmacokinetic and pharmacodynamic changes in pediatric analgesics, including paracetamol and NSAIDs, to improve pain management.
Area of Science:
- Pharmacology
- Pediatrics
- Drug Metabolism
Background:
- Pediatric drug development requires understanding growth and developmental changes.
- Pharmacokinetic (PK) and pharmacodynamic (PD) processes differ significantly between children and adults.
- Allometric scaling and pharmacogenomics (PG) are key tools for analyzing age-related drug response variations.
Purpose of the Study:
- To review recent data on analgesics for pediatric pain management.
- To focus on PK and clinical studies in neonates, infants, and children.
- To highlight the impact of age, genetics, and drug formulation on analgesic efficacy and safety.
Main Methods:
- Analysis of allometric scaling models for developmental clearance changes.
- Review of pharmacogenomic (PG) data on hepatic drug metabolism and receptor responses.
- Examination of PK and clinical studies in pediatric populations.
- Assessment of altered drug formulations and chemical structures for enhanced efficacy.
Main Results:
- Allometric scaling aids understanding of developmental clearance for analgesics like paracetamol and morphine.
- Pharmacogenomics (PG) impacts drug metabolism and receptor responses for opioids, NSAIDs, and tramadol.
- Altered formulations and stereoselectivity enhance safety and efficacy of NSAIDs, intravenous paracetamol, and local anesthetics.
- Limited data exists on age-related PD changes in children, despite known age-dependent receptor variations.
Conclusions:
- Pharmacokinetic and pharmacodynamic considerations are vital for optimizing pediatric pain management.
- Pharmacogenomics (PG) offers potential for personalized pediatric drug therapy, though its impact in neonates requires further study.
- Continued research into age-related PK/PD changes and the influence of genetics is essential for safe and effective analgesic use in children.
Related Concept Videos
01:29Local Anesthetics: Clinical Application as Epidural Anesthesia
Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
01:24Parenteral Anesthetics: Overview
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...